OakChart

Ashland Inc

ASHBasic Materials·Specialty Chemicals·USA·Mid·NYSE·Nov 12 • 3:59 PM ET

75.27-1.45 (-1.89%)
2026-11-13 12:58 CET
Market cap
$3.45B
Revenue, TTM
1,863.00 USD m
Net income, TTM
4.00 USD m
Free cash flow, TTM
295.00 USD m
EPS diluted, TTM
0.09
Price / earnings
865.17
Compare

Price

ASH against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 35Sales 406Price40440560.0070.0080.003.6M7.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ASHclose 75.2720-day 74.1350-day 71.81200-day 64.3375.2752w high 79.5052-week range, not 6 months

5.3% under the 52-week high of 79.50 on 6 Nov 2026. 52-week low 48.00 on 20 Nov 2025. Last 15 sessions, 10.4% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 35
CANSLIM 5 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%)
VCP 5 of 6 — fails: Average True Range: Under 2
Minervini 4 of 4
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 1 of 4 — fails: P/E: Under 15; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 2 of 4 — fails: Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 4 of 4
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

ASH
52-week range, 87% of the way up
48.0079.50

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

IndexRUT
Employees2900
IPOMay 08, 1950
Beta0.36
ATR, 14d2.04
Rel volume0.00
Short float11.23%
Insider own1.29%
Inst own115.90%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$3.45B
Enterprise Value4.44B
Income4.00M
Sales1.86B
Book / share40.84
Cash / share10.48
Dividend Est.1.41 (1.87%)
Dividend TTM1.67 (2.22%)
Dividend Ex-DateDec 01, 2026
Dividend Gr. 3/5Y5.06% 7.75%
Payout1919.54%
Employees2900
IPOMay 08, 1950

Ratios

Price / earnings865.17
Forward price / earnings15.29
Price / earnings / growth0.83
Price / sales1.85
Price / book1.84
Price / cash7.18
Price / free cash flow11.68
Value / cash profit12.57
Value / sales2.38
Quick Ratio1.89
Current Ratio2.96
Debt / equity0.80
Long-term debt / equity0.78
Options and shortYes / Yes

Earnings

Earnings / share0.09
Earnings next year4.92
Earnings next quarter0.38
Earnings this year27.53%
Earnings next year16.62%
Earnings growth, 5 years18.46%
Past earnings growth-70.41% -52.65%
Past sales growth-5.26% -2.47%
Earnings vs last year106.07%
Sales vs last year2.08%
Earnings vs last quarter-150.00%
Sales vs last quarter4.18%
EarningsNov 03 AMC
Surprise-12.12% -0.75%

Ownership

Insiders own1.29%
Insider trades0.00%
Institutions own115.90%
Institution trades-3.90%
Return on assets0.55%
Return on equity1.33%
Return on capital0.12%
Gross Margin27.48%
Operating margin7.25%
Profit Margin0.21%
20-day average1.54%
50-day average4.82%
200-day average17.00%

Technical

Shares out45.79M
Shares floating45.20M
Short / float11.23%
Short ratio8.11
Short interest5.08M
52-week high79.50 -5.3%
52-week low48.00 +56.8%
Volatility3.22% 2.58%
Average range2.04
Strength index56.46
Market sensitivity0.36
Relative volume0.00
Avg Volume625.72K
Volume0

Performance

Perf Week-1.32%
Perf Month5.54%
Perf Quarter2.12%
Perf Half Y34.05%
Perf YTD28.29%
Perf Year50.33%
Perf 3Y3.89%
Perf 5Y-29.18%
Perf 10Y43.06%
Recommendation1.46
Target Price82.45
Prev Close75.27
Price75.27
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 06, 2026UpgradeSeaport Research PartnersNeutral → Buy$75-0.4%
Dec 15, 2025UpgradeBMO Capital MarketsMarket Perform → Outperform$71-5.7%
Sep 08, 2025InitiatedMorgan StanleyEqual-Weight$60-20.3%
May 01, 2025DowngradeWells FargoOverweight → Equal Weight
Mar 26, 2025UpgradeJP MorganNeutral → Overweight$68 → $71-5.7%
Mar 05, 2025DowngradeSeaport Research PartnersBuy → Neutral
Aug 08, 2024UpgradeJP MorganUnderweight → Neutral$90 → $89+18.2%
Apr 11, 2024UpgradeWells FargoEqual Weight → Overweight$100 → $112+48.8%
Mar 14, 2024UpgradeJefferiesHold → Buy$100 → $126+67.4%
Mar 01, 2024InitiatedWolfe ResearchOutperform$108+43.5%

Peers

Mkt cap
TickerCompanyMkt cap
EMNEastman Chemical Co7.50B
BCPCBalchem Corp5.48B
IOSPInnospec Inc1.96B
SXTSensient Technologies Corp4.92B
AVNTAvient Corp4.12B
IFFInternational Flavors & Fragrances Inc20.13B
MTXMinerals Technologies Inc1.92B
SCLStepan Co1.51B
CBTCabot Corp3.71B
DOWDow Inc23.99B

Insider trading

latest 14 of 19
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
MUSA OSAMA MSVP and CTOSep 21 '26Option Exercise69.0610,418719,46741,224Sep 23 04:30 PM
LAMPKIN ROBIN E.SVP, GC & SecretaryAug 11 '26Option Exercise74.581,806134,6916,825Aug 12 04:30 PM
MUSA OSAMA MSVP and CTOJul 29 '26Option Exercise57.961,26773,43530,806Jul 30 04:30 PM
Assis Alessandra FaccinSVP and GM, Life SciencesJul 27 '26Option Exercise66.383,215213,4129,099Jul 29 04:30 PM
MINICUCCI JAMES P.SVP and GM, Personal CareMay 08 '26Option Exercise55.014,310237,0938,567May 11 04:30 PM
Kulkarni Ashish KDirectorJan 21 '26Option Exercise0.002,11302,113Jan 22 04:30 PM
NOVO GUILLERMOChair of the Board and CEONov 17 '25Option Exercise49.606,122303,651143,412Nov 19 04:30 PM
Drury EileenSVP and Chief HRONov 17 '25Option Exercise49.6056728,1237,881Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 17 '25Option Exercise49.6097648,41029,875Nov 19 04:30 PM
MUSA OSAMA MSVP and CTONov 14 '25Option Exercise51.512,091107,70729,616Nov 19 04:30 PM
RICHARDSON SAMUELVP, Controller and PAONov 17 '25Option Exercise49.601075,3071,104Nov 19 04:30 PM
WHITAKER WILLIAMSVP, CFO & PFONov 17 '25Option Exercise49.601075,3072,082Nov 19 04:30 PM
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 17 '25Option Exercise49.6023911,8545,095Nov 19 04:30 PM
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 14 '25Option Exercise51.511,27665,7275,237Nov 17 09:43 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 125.56B
AVUVAvantis U.S. Small Cap Value ETFAUM: 33.08B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.56B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.54B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.88B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWNiShares Russell 2000 Value ETFAUM: 14.17B

News

latest 14 of 200
  • Ashland board authorizes quarterly dividend (GlobeNewswire)
  • Ashland Misses On EPS As Hopewell Drag Offsets Record Specialty Margins; FY27 Outlook Rests On Plant Recovery (Earnings Whispers)
  • Ashland: Fiscal Q4 Earnings Snapshot (Associated Press)
  • Ashland reports fourth quarter and full-year fiscal 2026 results and issues outlook for fiscal 2027 (GlobeNewswire)
  • Ashland sets date for fourth-quarter fiscal 2026 earnings release and conference call webcast (GlobeNewswire)
  • Ashland's Growth Rebound Faces A Margin Test As Hopewell Drag Lingers Into Year-End (Earnings Whispers)
  • Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer eco-disperse OD polymeric dispersant (GlobeNewswire)
  • Ashland Innovation Day to be held September 17, 2026 (GlobeNewswire)
  • Ashland to host Innovation Day for analysts and investors (GlobeNewswire)
  • Ashland advances high-growth oral biologics delivery applications with launch of permexa sodium caprate (GlobeNewswire)
  • Ashland board authorizes quarterly dividend (GlobeNewswire) +5.51%
  • Ashland Inc (ASH) Q3 2026 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ... (GuruFocus.com) +7.10%
  • Ashland: Fiscal Q3 Earnings Snapshot (Associated Press)
  • Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook (GlobeNewswire)

Quarterly earnings

2026Q4 EPS 1.120 missed 1.275, from 1.080 a year earlier. Sales 498 missed 501.76, from 478 a year earlier
EPS
1.27502025Q1 EPS 0.280 against 0.17025Q12025Q2 EPS 0.990 against 1.10325Q22025Q3 EPS 1.040 against 1.20525Q32025Q4 EPS 1.080 against 1.24325Q42026Q1 EPS 0.260 against 0.26026Q12026Q2 EPS 0.910 against 0.95826Q22026Q3 EPS 1.020 against 0.98526Q32026Q4 EPS 1.120 against 1.27526Q4
Sales, USD millions
502.6202025Q1 sales 405 against 429.0625Q12025Q2 sales 479 against 502.6225Q22025Q3 sales 463 against 476.5825Q32025Q4 sales 478 against 482.325Q42026Q1 sales 386 against 400.8726Q12026Q2 sales 482 against 485.6126Q22026Q3 sales 497 against 485.9826Q32026Q4 sales 498 against 501.7626Q4

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q4ended 2026-09-302026-11-03 16:301.1201.275-0.350498501.76EPS -12.1% · sales -0.7%vs 2025Q4, year-ago quarter · EPS +3.7% · sales +4.2%10 EPS · 8 salesOpen +0.71% vs SPY +1.15%. Close +4.68% vs SPY +1.65%
2026Q3ended 2026-06-302026-07-28 16:301.0200.9850.348497485.98EPS +3.6% · sales +2.3%vs 2025Q3, year-ago quarter · EPS -1.9% · sales +7.3%10 EPS · 8 salesOpen +7.34% vs SPY -0.12%. Close +7.10% vs SPY -1.54%
2026Q2ended 2026-03-312026-04-28 16:300.9100.9580.348482485.61EPS -5.0% · sales -0.7%vs 2025Q2, year-ago quarter · EPS -8.1% · sales +0.6%10 EPS · 8 salesOpen -3.86% vs SPY -0.10%. Close -13.77% vs SPY -0.02%
2026Q1ended 2025-12-312026-02-02 16:300.2600.260-0.261386400.87EPS +0.2% · sales -3.7%vs 2025Q1, year-ago quarter · EPS -7.1% · sales -4.7%10 EPS · 8 salesOpen -3.25% vs SPY +0.12%. Close -0.78% vs SPY -0.85%
2025Q4ended 2025-09-302025-11-04 16:301.0801.2430.696478482.3EPS -13.1% · sales -0.9%vs 2024Q4, year-ago quarter · EPS -14.3% · sales -8.4%9 EPS · 8 salesOpen +0.36% vs SPY -0.04%. Close +6.06% vs SPY +0.35%
2025Q3ended 2025-06-302025-07-29 16:301.0401.205-16.130463476.58EPS -13.7% · sales -2.8%vs 2024Q3, year-ago quarter · EPS -30.2% · sales -14.9%9 EPS · 8 salesOpen +0.64% vs SPY +0.10%. Close +5.58% vs SPY -0.13%
2025Q2ended 2025-03-312025-04-30 16:300.9901.1030.681479502.62EPS -10.3% · sales -4.7%vs 2024Q2, year-ago quarter · EPS -22.0% · sales -16.7%8 EPS · 7 salesOpen -9.45% vs SPY +1.05%. Close -9.85% vs SPY +0.71%
2025Q1ended 2024-12-312025-01-28 16:300.2800.170-3.511405429.06EPS +65.0% · sales -5.6%vs 2024Q1, year-ago quarter · EPS -37.8% · sales -14.4%9 EPS · 7 salesOpen -1.77% vs SPY -0.13%. Close -9.82% vs SPY -0.45%
2024Q4ended 2024-09-302024-11-06 16:301.2601.2820.327522524.07EPS -1.7% · sales -0.4%vs 2023Q4, year-ago quarter · EPS +207.3% · sales +0.8%8 EPS · 7 salesOpen -8.43% vs SPY +0.35%. Close -7.64% vs SPY +0.77%
2024Q3ended 2024-06-302024-08-06 16:301.4901.4480.275544574.41EPS +2.9% · sales -5.3%vs 2023Q3, year-ago quarter · EPS +21.1% · sales -0.4%8 EPS · 9 salesOpen -8.42% vs SPY +1.21%. Close -9.57% vs SPY -0.67%
2024Q2ended 2024-03-312024-04-30 16:301.2701.1442.353575574.64EPS +11.0% · sales +0.1%vs 2023Q2, year-ago quarter · EPS -11.2% · sales -4.6%9 EPS · 8 salesOpen +1.98% vs SPY -0.12%. Close -0.87% vs SPY -0.32%
2024Q1ended 2023-12-312024-01-30 16:300.4500.1970.569473478.75EPS +129.0% · sales -1.2%vs 2023Q1, year-ago quarter · EPS -53.6% · sales -9.9%9 EPS · 8 salesOpen +11.11% vs SPY -0.46%. Close +15.91% vs SPY -1.63%
2023Q4ended 2023-09-302023-11-08 16:300.4100.687-0.098518528.57EPS -40.3% · sales -2.0%vs 2022Q4, year-ago quarter · EPS -71.9% · sales -17.9%9 EPS · 8 sales-
2023Q3ended 2023-06-302023-07-25 16:301.2301.3200.962546559.38EPS -6.8% · sales -2.4%vs 2022Q3, year-ago quarter · EPS -34.9% · sales -15.2%11 EPS · 9 sales-
2023Q2ended 2023-03-312023-05-02 16:301.4301.4651.655603625.96EPS -2.4% · sales -3.7%vs 2022Q2, year-ago quarter · EPS -4.7% · sales -0.2%12 EPS · 10 sales-
2023Q1ended 2022-12-312023-01-31 16:300.9700.9760.745525526.89EPS -0.6% · sales -0.4%vs 2022Q1, year-ago quarter · EPS +10.2% · sales +2.5%12 EPS · 10 sales-

Annual earnings

2026FY EPS 3.310 missed 3.500, from 3.380 a year earlier. Sales 1,863 missed 1,866, from 1,824 a year earlier
EPS
5.70002019FY EPS 2.505 against 2.70220192020FY EPS 3.030 against 2.63820202021FY EPS 4.430 against 4.55720212022FY EPS 5.700 against 5.64120222023FY EPS 4.040 against 4.37620232024FY EPS 4.450 against 4.45120242025FY EPS 3.380 against 3.55320252026FY EPS 3.310 against 3.5002026
Sales, USD millions
2,51802019FY sales 2,500 against 2,51820192020FY sales 2,326 against 2,31120202021FY sales 2,378 against 2,36820212022FY sales 2,391 against 2,39020222023FY sales 2,192 against 2,20120232024FY sales 2,100 against 2,11720242025FY sales 1,824 against 1,82720252026FY sales 1,863 against 1,8662026

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2029FYestimate-5.502--2,09613.68
2028FYestimate-4.923--2,01615.29
2027FYestimate-4.221--1,93417.83
2026FY3.3103.5000.0801,8631,86620.52
2025FY3.3803.553-18.3701,8241,82714.18
2024FY4.4504.4513.3802,1002,11719.54
2023FY4.0404.3763.3592,1922,20120.22
2022FY5.7005.641-2.4732,3912,39016.66
2021FY4.4304.5573.6562,3782,36820.12
2020FY3.0302.638-8.9342,3262,31123.41
2019FY2.5052.7028.0162,5002,51830.76
2018FY3.5803.5741.7813,7433,73523.43
2017FY2.4404.3720.0163,2604,24226.80
2016FY3.2833.345-0.4604,9484,94322.93
2015FY3.4353.3752.1925,3875,40821.92
2014FY2.9362.9391.4686,1216,43825.64
2013FY2.9602.9854.1937,8137,83025.43
2012FY3.2443.1620.1628,2068,26023.20
2011FY1.7521.7182.5306,5026,40442.97
2010FY4.1702.0512.0459,0128,98418.05

Quarterly results

2026Q4 revenue 498, from 478 a year earlier. Operating margin 7.6%, from 12.8% a year earlier
Revenue, USD millions
49802025Q1 revenue 40525Q12025Q2 revenue 47925Q22025Q3 revenue 46325Q32025Q4 revenue 47825Q42026Q1 revenue 38626Q12026Q2 revenue 48226Q22026Q3 revenue 49726Q32026Q4 revenue 49826Q4
Operating margin
12.80-3.52025Q1 operating margin 5.7%25Q12025Q2 operating margin 6.1%25Q22025Q3 operating margin -3.5%25Q32025Q4 operating margin 12.8%25Q42026Q1 operating margin -1.6%26Q12026Q2 operating margin 10.6%26Q22026Q3 operating margin 10.5%26Q32026Q4 operating margin 7.6%26Q4

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2027FY E 4.22 per share.
PeriodTypeScaleDateMeanvs prior date
2027FYEper share2026-11-094.220.0%
2027Q1Eper share2026-11-090.38+0.1%
2027FYSUSD millions2026-11-061,934+0.0%
2027Q1S-2026-11-06405.97+0.1%
2027FYRper share2026-11-052.88+0.5%
2027Q1Rper share2026-11-050.08+433.5%
2026FYEper share2026-10-203.50-0.2%
2026Q4Eper share2026-10-201.27-0.6%
2026FYRper share2026-10-202.16-1.2%
2026Q4Rper share2026-10-200.98-3.8%
2026FYSUSD millions2026-10-201,866+0.0%
2026Q4S-2026-10-20501.76+0.0%
2026Q3Eper share2026-07-291.00+1.5%
2026Q3Rper share2026-07-290.74+7.9%
2026Q3S-2026-07-29489.4+0.7%
2026Q2S-2026-04-28485.610.0%
2026Q2Eper share2026-04-270.96-0.4%
2026Q2Rper share2026-04-190.730.0%
2026Q1Eper share2026-01-260.240.0%
2026Q1S-2026-01-24402.120.0%
2026Q1Rper share2026-01-09-0.06-0.6%
2025FYSUSD millions2025-10-311,8270.0%
2025Q4S-2025-10-19482.30.0%
2025FYEper share2025-10-143.550.0%
2025Q4Eper share2025-10-141.24+0.0%
2025FYRper share2025-10-14-2.73-213.8%
2025Q4Rper share2025-09-260.95-7.5%
2025Q3S-2025-07-27476.580.0%
2025Q3Eper share2025-07-171.20-2.7%
2025Q3Rper share2025-07-170.86-7.2%
2025Q2S-2025-04-26502.620.0%
2025Q2Eper share2025-04-181.10+0.1%
2025Q2Rper share2025-04-180.810.0%
2025Q1S-2025-01-21429.06-0.4%
2025Q1Eper share2025-01-170.17-25.0%
2025Q1Rper share2025-01-090.08-59.2%
2024FYEper share2024-10-264.450.0%
2024FYSUSD millions2024-10-222,1170.0%
2024Q4Eper share2024-10-211.280.0%
2024Q4S-2024-10-21524.070.0%
2024FYRper share2024-10-173.30-0.5%
2024Q4Rper share2024-10-171.04-2.1%
2024Q3Eper share2024-07-201.450.0%
2024Q3Rper share2024-07-171.170.0%
2024Q3S-2024-07-17577.080.0%
2024Q2Eper share2024-04-181.14-2.4%
2024Q2S-2024-04-16574.640.0%
2024Q2Rper share2024-04-150.870.0%
2023FYEper share2023-11-014.38-2.6%
2023FYRper share2023-11-013.06-2.3%
2023FYSUSD millions2023-11-012,201+0.1%

Estimate history

Annual
Metric201820192020202120222023202420252026MRQ
EPS per share1.7818.016-8.9343.656-2.4733.3593.38-18.370.087-
Sales USD millions2,5892,4932,0162,1112,3912,1912,1131,8241,863-
Shares million shares6260605754514746-46
Quarterly
MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
EPS per share0.327-3.5110.681-16.130.696-0.2610.3480.348-0.348
Sales USD millions522405479463478386482497498
Shares million shares4747464646464646-

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2026FY9/30/20262025FY9/30/20252024FY9/30/20242023FY9/30/20232022FY9/30/20222021FY9/30/20212020FY9/30/20202019FY9/30/2019
Total Revenue1,863.001,863.00+2.1%1,824.00-13.7%2,113.00-3.6%2,191.00-8.4%2,391.00+13.3%2,111.00+4.7%2,016.00-19.1%2,493.00
Cost of Goods Sold Incl. D&A1,351.001,322.00-4.7%1,387.00-14.4%1,620.00-3.0%1,670.00-3.0%1,722.00+12.5%1,531.00+2.0%1,501.00-13.0%1,726.00
Gross Profit512.00541.00+23.8%437.00-11.4%493.00-5.4%521.00-22.1%669.00+15.3%580.00+12.6%515.00-32.9%767.00
Selling, General and Administrative Excl. Other377.00432.00+27.4%339.00-10.3%378.00+7.1%353.00+4.7%337.00-14.7%395.00-0.5%397.00-13.5%459.00
Research and Development56.0055.00+1.9%54.00-1.8%55.00+7.8%51.00-7.3%55.00+10.0%50.00-10.7%56.00-15.2%66.00
Other Operating Expense--0.000.000.000.000.000.000.00
Operating Income135.00109.00+11.2%98.00-14.8%115.00-31.5%168.00-49.4%332.00+79.5%185.00+56.8%118.00-61.7%308.00
Interest Expense72.0040.00-36.5%63.00+14.5%55.00-3.5%57.00-13.6%66.00-9.6%73.00-19.8%91.00-22.9%118.00
Unusual Expense37.008.00-98.9%716.00+2137.5%32.00+255.6%9.00-79.5%44.00+100.0%22.00-96.6%642.00+368.6%137.00
Net Income Before Taxes70.0069.00-809.00-24.00-115.0%160.00-22.3%206.00+52.6%135.00-577.00-924.3%70.00
Income Taxes45.0044.00+238.5%13.00-223.00-8.00-132.0%25.00-38.00-22.00-147.8%46.00
Consolidated Net Income25.0025.00-822.00-513.1%199.00+18.5%168.00-7.2%181.00+4.6%173.00-555.00-2412.5%24.00
Net Income From Continuing Operations25.0025.00-822.00-513.1%199.00+18.5%168.00-7.2%181.00+4.6%173.00-555.00-2412.5%24.00
Net Income4.004.00-845.00-600.0%169.00-5.1%178.00-136.00-161.0%223.00-545.00-207.9%505.00
EPS (Recurring) per share0.650.21-7.47-295.0%3.83+12.3%3.41-1.88-148.1%3.91-1.57-116.5%9.54
EPS (Basic, Before Extraordinaries) per share---18.37-632.5%3.45+2.7%3.36-2.47-166.4%3.72-8.93-209.6%8.15
EPS (Diluted) per share0.090.09-18.37-643.5%3.38+0.6%3.36-2.47-167.5%3.66-8.93-211.3%8.02
EBITDA353.00294.00-23.8%386.00-13.1%444.00-5.1%468.00-26.9%640.00+33.3%480.00+19.4%402.00-28.1%559.00
Non-Operating Income (Expense)39.008.00-128.00-52.00-189.7%58.00-16.00-135.6%45.00+18.4%38.00+123.5%17.00
Other After Tax Adjustments--0.000.000.000.000.000.000.00
Stock Option Compensation Expense--10.00-28.6%14.00-17.6%17.00-5.6%18.00+28.6%14.00+16.7%12.00-40.0%20.00
Price To Earnings Ratio ratio statement ratio, not the snapshot865.17865.17-28.07--24.37-9.36
Price To Sales Ratio ratio1.681.681.212.062.012.222.582.151.95
Gross Margin %27.4829.0423.9623.3323.7827.9827.4825.5530.77
Operating Margin %7.255.855.375.447.6713.898.765.8512.35
Net Margin %0.210.21-46.338.008.12-5.6910.56-27.0320.26
Shares Outstanding million shares--46.00-2.1%47.00-7.8%51.00-5.6%54.00-5.3%57.00-5.7%60.47+0.8%60.00
Market Capitalization3,446.873,446.87+57.4%2,189.77-48.4%4,246.91+1.5%4,185.36-18.6%5,141.62-5.0%5,412.56+26.2%4,288.57-8.0%4,663.22

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q49/30/20262026Q36/30/20262026Q23/31/20262026Q112/31/20252025Q49/30/20252025Q36/30/20252025Q23/31/20252025Q112/31/2024
Total Revenue498.00+4.2%497.00+7.3%482.00+0.6%386.00-4.7%478.00-8.4%463.00-14.9%479.00-16.7%405.00-14.4%
Cost of Goods Sold Incl. D&A333.00-0.6%362.00-7.9%350.00+0.3%306.00-1.6%335.00-9.0%393.00-6.0%349.00-19.8%311.00-22.1%
Gross Profit165.00+15.4%135.00+92.9%132.00+1.5%80.00-14.9%143.00-7.1%70.00-44.4%130.00-7.1%94.00+27.0%
Selling, General and Administrative Excl. Other127.00+54.9%83.00-3.5%81.00-19.8%86.00+21.1%82.00-23.4%86.00+2.4%101.000.0%71.00-21.1%
Research and Development14.00+7.7%15.00+15.4%14.000.0%13.000.0%13.000.0%13.00-13.3%14.000.0%13.00+8.3%
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income38.00-37.7%52.0051.00+75.9%-6.00-126.1%61.00+29.8%-16.00-138.1%29.00-25.6%23.00
Interest Expense21.00+31.3%17.00-5.6%17.00-5.6%17.00-5.6%16.00+6.7%18.00+28.6%18.00+12.5%18.00+20.0%
Unusual Expense11.00+83.3%11.00-98.4%12.003.00-85.0%6.00+50.0%692.00+17200.0%-4.00-122.2%20.00+900.0%
Net Income Before Taxes9.00-85.9%56.0020.00-48.7%-15.0064.00+156.0%-704.0039.00+129.4%-209.00-5325.0%
Income Taxes26.00-16.1%15.000.0%5.00-44.4%-1.0031.00+416.7%15.009.00-43.00
Consolidated Net Income-17.00-151.5%41.0015.00-50.0%-14.0033.00+73.7%-719.00-2419.4%30.00-75.2%-166.00-692.9%
Net Income From Continuing Operations-17.00-151.5%41.0015.00-50.0%-14.0033.00+73.7%-719.00-2419.4%30.00-75.2%-166.00-692.9%
Net Income-16.00-150.0%16.0016.00-50.0%-12.0032.00+100.0%-742.00-5400.0%32.00-73.3%-165.00-669.0%
EPS (Recurring) per share-0.18-122.8%0.520.53-14.5%-0.220.79+107.9%-5.60-1797.0%0.62-76.2%-3.21-635.0%
EPS (Basic, Before Extraordinaries) per share-0.350.35-48.5%-0.260.70+105.9%-16.13-5860.7%0.68-71.7%-3.51-715.8%
EPS (Diluted) per share-0.35-150.0%0.350.35-48.5%-0.260.70+112.1%-16.13-6074.1%0.68-71.1%-3.51-715.8%
EBITDA83.00-25.9%121.00+14.2%97.00+6.6%52.00-30.7%112.00+7.7%106.00-27.4%91.00-27.2%75.00+15.4%
Non-Operating Income (Expense)3.00-88.0%32.00+45.5%-2.00-108.3%11.0025.0022.0024.00+100.0%-194.00-624.3%
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-4.74+100.0%3.950.0%3.95+25.0%1.58-65.0%2.37-25.0%3.95-28.6%3.16+300.0%
Price To Earnings Ratio ratio statement ratio, not the snapshot865.17------20.29
Price To Sales Ratio ratio1.681.641.411.491.211.241.431.64
Gross Margin %33.1327.1627.3920.7329.9215.1227.1423.21
Operating Margin %7.6310.4610.58-1.5512.76-3.466.055.68
Net Margin %-3.213.223.32-3.116.69-160.266.68-40.74
Shares Outstanding million shares-45.79+0.2%45.79+0.2%45.76-3.0%46.00-2.1%45.71-6.4%45.69-8.9%47.18-5.8%
Market Capitalization3,446.87+57.4%3,016.96+31.3%2,544.85-9.0%2,684.86-20.4%2,189.77-48.4%2,297.52-51.5%2,797.47-42.6%3,371.51-21.3%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026FY9/30/20262025FY9/30/20252024FY9/30/20242023FY9/30/20232022FY9/30/20222021FY9/30/20212020FY9/30/20202019FY9/30/20192018FY9/30/2018
Cash & Short Term Investments480.00+81.1%265.00-29.0%373.00-24.5%494.00-30.1%707.00+186.2%247.00-49.0%484.00+89.1%256.00-21.0%324.00
Short Term Receivables266.00+9.9%242.00-0.4%243.00-28.1%338.00-15.7%401.00+9.0%368.00-15.6%436.00-9.4%481.00-7.9%522.00
Inventories482.00-15.1%568.00+4.2%545.00-12.9%626.00-0.5%629.00+33.0%473.00-6.5%506.00-15.2%597.00+0.2%596.00
Other Current Assets108.00-16.9%130.00+282.4%34.00-29.2%48.00+54.8%31.00-95.1%629.00+419.8%121.00+22.2%99.00-63.3%270.00
Total Current Assets1,336.00+10.9%1,205.00+0.8%1,195.00-20.7%1,506.00-14.8%1,768.00+3.0%1,717.00+11.0%1,547.00+8.0%1,433.00-16.3%1,712.00
Net Property, Plant & Equipment1,233.00-5.4%1,304.00-8.0%1,417.00-5.2%1,495.00+3.5%1,445.00-6.8%1,551.00-3.7%1,611.00+2.2%1,577.00-4.2%1,646.00
Total Investments and Advances248.00-17.3%300.00+0.7%298.00+1.7%293.00-7.3%316.00-18.6%388.00+26.8%306.00-3.2%316.00-1.2%320.00
Long-Term Note Receivable137.00-1.4%139.00-2.8%143.00+0.7%142.00-8.4%155.00+5.4%147.00-1.3%149.00-11.8%169.00-5.6%179.00
Intangible Assets1,196.00-5.7%1,268.00-40.5%2,132.00-5.2%2,248.00-1.2%2,275.00-10.0%2,529.00+9.2%2,316.00-30.7%3,341.00-4.2%3,489.00
Deferred Tax Assets138.00-12.1%157.00-25.2%210.00+854.5%22.00+10.0%20.00-33.3%30.00+15.4%26.00+13.0%23.00-17.9%28.00
Other Assets239.00+0.4%238.00-4.8%250.00+7.3%233.00-0.4%234.00-6.4%250.00-72.9%922.00+135.2%392.00-55.7%885.00
Total Assets4,527.00-1.8%4,611.00-18.3%5,645.00-5.0%5,939.00-4.4%6,213.00-6.0%6,612.00-3.9%6,877.00-5.2%7,251.00-12.2%8,259.00
Short Term Debt Incl. Current Port. of LT Debt22.00+4.8%21.00+5.0%20.00-47.4%38.00+100.0%19.00-95.2%397.00+31.5%302.00+81.9%166.00-34.6%254.00
Accounts Payable210.00+11.1%189.00-11.7%214.00+1.9%210.00-20.8%265.00+12.3%236.00+11.8%211.00-32.6%313.00-5.4%331.00
Other Current Liabilities220.00+3.3%213.00-16.8%256.00+23.1%208.00-22.7%269.00-10.6%301.00+0.3%300.00+7.9%278.00-43.4%491.00
Total Current Liabilities452.00+6.9%423.00-13.7%490.00+7.5%456.00-17.5%553.00-40.8%934.00+14.9%813.00+7.4%757.00-29.6%1,076.00
Long Term Debt1,450.00-1.3%1,469.00+1.5%1,448.00+2.0%1,420.00+4.1%1,364.00-20.0%1,706.00+1.1%1,687.00+12.4%1,501.00-34.0%2,275.00
Provision for Risks Charges462.00-30.4%664.00-3.5%688.00-0.6%692.00-5.5%732.00-6.9%786.00-4.1%820.00-3.3%848.00-7.3%915.00
Deferred Tax Liabilities24.00-22.6%31.00+6.9%29.00-80.4%148.00-15.9%176.00-25.7%237.00+3.5%229.00-13.3%264.00-7.7%286.00
Other Liabilities291.00+142.5%120.00-1.6%122.00-3.2%126.00-25.0%168.00-14.7%197.00-32.5%292.00-5.8%310.00+3.0%301.00
Total Liabilities2,679.00-1.0%2,707.00-2.5%2,777.00-2.3%2,842.00-5.0%2,993.00-22.5%3,860.00+0.5%3,841.00+4.4%3,680.00-24.2%4,853.00
Non-Equity Reserves-0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,848.00-2.9%1,904.00-33.6%2,868.00-7.4%3,097.00-3.8%3,220.00+17.0%2,752.00-9.4%3,036.00-15.0%3,571.00+4.8%3,406.00
Total Shareholders Equity1,848.00-2.9%1,904.00-33.6%2,868.00-7.4%3,097.00-3.8%3,220.00+17.0%2,752.00-9.4%3,036.00-15.0%3,571.00+4.8%3,406.00
Accumulated Minority Interest-0.000.000.000.000.000.000.000.00
Total Equity1,848.00-2.9%1,904.00-33.6%2,868.00-7.4%3,097.00-3.8%3,220.00+17.0%2,752.00-9.4%3,036.00-15.0%3,571.00+4.8%3,406.00
Total Liabilities & Stockholders Equity4,527.00-1.8%4,611.00-18.3%5,645.00-5.0%5,939.00-4.4%6,213.00-6.0%6,612.00-3.9%6,877.00-5.2%7,251.00-12.2%8,259.00
Book Value Per Share per share-41.39-32.2%61.02+0.5%60.73+1.8%59.63+23.5%48.28-3.8%50.21-15.6%59.52+8.3%54.94
Tangible Book Value Per Share per share-13.83-11.7%15.66-5.9%16.65-4.9%17.50+347.6%3.91-67.2%11.91+211.0%3.83-1.34
Full-Time Employees people-2,900-9.4%3,200-15.8%3,800-2.6%3,900-4.9%4,100-8.9%4,500-4.3%4,700-21.7%6,000
Price to Book Ratio ratio1.841.161.431.331.591.851.421.291.54
Return on Assets %0.55-16.033.442.762.822.57-7.860.310.23
Return on Equity %1.33-34.456.675.326.065.98-16.800.690.56
Return on Invested Capital %0.12-25.053.923.94-2.975.00-11.549.962.01
Quick Ratio ratio1.891.511.331.932.061.331.281.101.04
Current Ratio ratio2.962.852.443.303.201.841.901.891.59

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2026FY9/30/20262025FY9/30/20252024FY9/30/20242023FY9/30/20232022FY9/30/20222021FY9/30/20212020FY9/30/20202019FY9/30/2019
Net Income4.004.00-2,489.00-1572.8%169.00-5.1%178.00-80.8%927.00+321.4%220.00-508.00-200.6%505.00
Depreciation185.00185.00-21.9%237.00-13.5%274.00+12.8%243.00+0.8%241.00-1.2%244.00+3.8%235.00-18.7%289.00
Other Funds (Non Cash)29.0029.00-98.8%2,504.00+2563.8%94.00-37.00-703.00-52.00-109.8%533.00-457.00
Funds from Operations225.00225.00-30.8%325.00+38.3%235.00-33.2%352.00-18.1%430.00+11.4%386.00+77.1%218.00-38.9%357.00
Extraordinary Item--0.000.000.000.000.000.000.00
Changes in Working Capital158.00158.00-191.00-184.1%227.00-58.00-237.00-396.3%80.00+788.9%9.00-129.00
Cash from Operating Activities383.00383.00+185.8%134.00-71.0%462.00+57.1%294.00+52.3%193.00-58.6%466.00+105.3%227.00-0.4%228.00
Capital Expenditures-88.00-88.00-98.00-137.00-170.00-113.00-105.00-133.00-154.00
Net Assets From Acquisitions--0.000.000.000.00-309.000.00-2.00
Sale of Fixed Assets and Businesses6.006.00-62.5%16.000.00-100.0%11.00-78.4%51.00+920.0%5.000.0%5.00-44.4%9.00
Purchase or Sale of Investments74.0074.00+15.6%64.00-19.0%79.00+36.2%58.00+65.7%35.00+6.1%33.00-5.7%35.00+40.0%25.00
Purchase of Investments-71.00-71.00-54.00-53.00-47.00-87.00-149.00-21.00-355.00
Sale Or Maturity of Investments145.00145.00+22.9%118.00-10.6%132.00+25.7%105.00-13.9%122.00-33.0%182.00+225.0%56.00-85.3%380.00
Other Uses-59.00-59.00-53.00-71.00-65.00-78.00-97.00-9.00-2.00
Other Sources29.0029.00+3.6%28.00+3.7%27.00+350.0%6.00-99.5%1,255.00+574.7%186.00+116.3%86.00-91.3%986.00
Cash from Investing Activities-38.00-38.00-43.00-102.00-160.00-113.9%1,150.00-287.00-16.00-101.9%862.00
Cash Dividends Paid-76.00-76.00-76.00-78.00-76.00-70.00-70.00-66.00-64.00
Change in Capital Stock0.000.00-100.00-380.00-300.00-200.00-450.000.00-200.00
Repurchase of Common Pref Stock0.000.00-100.00-380.00-300.00-200.00-450.000.00-200.00
Sale of Common Pref Stock--0.000.000.000.000.000.000.00
Proceedsfrom Stock Options--0.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net--0.00-16.00-200.0%16.00-615.00-708.9%101.00+23.2%82.00-875.00
Change in Long Term Debt--0.000.000.00-250.00-1570.6%17.00-33.00-797.00
Issuance of Long Term Debt--0.000.000.000.00-100.0%444.00-44.0%793.000.00
Reduction of Long Term Debt--0.000.000.00-250.00-427.00-826.00-797.00
Net Financing Active Other Cash Flow-3.00-3.00-3.00-5.00-11.00-9.00-7.00-7.00-10.00
Other Financing Activities Uses-3.00-3.00-3.00-5.00-11.00-9.00-7.00-7.00-10.00
Cash from Financing Activities-79.00-79.00-179.00-479.00-371.00-896.00-426.00-4833.3%9.00-1,149.00
Exchange Rate Effect-1.00-1.00-133.3%3.00+50.0%2.00-75.0%8.00-11.00-466.7%3.00+50.0%2.00-3.00
Net Change in Cash265.00265.00-85.00-117.00-229.00-152.5%436.00-244.00-209.9%222.00-62.00
Free Cash Flow295.00295.00+719.4%36.00-88.9%325.00+162.1%124.00+55.0%80.00-77.8%361.00+284.0%94.00+27.0%74.00
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Price to Free Cash Flow ratio14.2714.27-17.6191.89531.8318.68154.50485.42
Deferred Taxes & Investment Tax Credit-7.00-90.4%73.00-302.00-32.00-35.00-26.00-42.00-310.0%20.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q49/30/20262026Q36/30/20262026Q23/31/20262026Q112/31/20252025Q49/30/20252025Q36/30/20252025Q23/31/20252025Q112/31/2024
Cash & Short Term Investments480.00+81.1%487.00+77.7%393.00+63.1%354.00+21.2%265.00-29.0%274.00-42.3%241.00-53.3%292.00-43.5%
Short Term Receivables266.00+9.9%256.00+27.4%244.00+8.0%190.00+16.6%242.00-0.4%201.00-10.3%226.00-13.1%163.00-16.0%
Inventories482.00-15.1%490.00-13.6%506.00-6.6%565.00+7.0%568.00+4.2%567.00+6.6%542.00-1.5%528.00-10.2%
Other Current Assets108.00-16.9%59.00-28.0%66.000.0%45.00-47.7%130.00+282.4%82.00-46.8%66.00-34.7%86.00+30.3%
Total Current Assets1,336.00+10.9%1,292.00+14.9%1,209.00+12.5%1,154.00+8.0%1,205.00+0.8%1,124.00-18.8%1,075.00-24.7%1,069.00-21.7%
Net Property, Plant & Equipment1,233.00-5.4%1,249.00-4.1%1,264.00-4.1%1,281.00-3.9%1,304.00-8.0%1,302.00-7.7%1,318.00-9.5%1,333.00-10.5%
Total Investments and Advances248.00-17.3%285.00+0.7%276.00+1.5%297.00+7.2%300.00+0.7%283.00-1.4%272.00-11.1%277.00-12.1%
Intangible Assets1,196.00-5.7%1,213.00-5.5%1,229.00-36.5%1,255.00-34.6%1,268.00-40.5%1,283.00-39.3%1,936.00-13.2%1,918.00-15.5%
Deferred Tax Assets138.00-12.1%157.00-34.9%157.00-34.9%157.00-34.9%157.00-25.2%241.00+50.6%241.00+60.7%241.00+435.6%
Other Assets239.00+0.4%243.00-6.2%242.00-8.7%251.00-4.9%238.00-4.8%259.00+1.2%265.00+8.2%264.00+8.2%
Total Assets4,527.00-1.8%4,578.00-0.9%4,499.00-14.0%4,519.00-13.6%4,611.00-18.3%4,621.00-19.6%5,233.00-12.0%5,231.00-10.8%
Short Term Debt Incl. Current Port. of LT Debt22.00+4.8%18.00-5.3%19.00-72.5%19.00-5.0%21.00+5.0%19.00-9.5%69.00+228.6%20.00-9.1%
Accounts Payable210.00+11.1%198.00+7.0%181.00-2.2%167.00-9.2%189.00-11.7%185.00-6.6%185.00-10.6%184.00-8.9%
Other Current Liabilities220.00+3.3%208.00-3.7%195.00-6.7%180.00-18.6%213.00-16.8%216.00-11.8%209.00-7.1%221.00+16.3%
Total Current Liabilities452.00+6.9%424.00+1.0%395.00-14.7%366.00-13.9%423.00-13.7%420.00-9.5%463.00+2.2%425.00+2.7%
Long Term Debt1,450.00-1.3%1,458.00-0.5%1,459.00+2.9%1,470.00+5.3%1,469.00+1.5%1,466.00+2.9%1,418.00-0.8%1,396.00-3.6%
Provision for Risks Charges462.00-30.4%671.00-4.1%629.00-3.4%650.00-3.0%664.00-3.5%700.00-0.8%651.00+0.9%670.00+0.3%
Deferred Tax Liabilities24.00-22.6%31.00+10.7%31.00+6.9%31.00+10.7%31.00+6.9%28.00-34.9%29.00-80.4%28.00-81.1%
Other Liabilities291.00+142.5%124.00+5.1%119.00+5.3%124.00+3.3%120.00-1.6%118.00-16.9%113.00-18.7%120.00-11.1%
Total Liabilities2,679.00-1.0%2,708.00-0.9%2,633.00-1.5%2,641.00+0.1%2,707.00-2.5%2,732.00-1.7%2,674.00-5.0%2,639.00-6.2%
Non-Equity Reserves-0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,848.00-2.9%1,870.00-1.0%1,866.00-27.1%1,878.00-27.5%1,904.00-33.6%1,889.00-36.3%2,559.00-18.3%2,592.00-15.1%
Total Shareholders Equity1,848.00-2.9%1,870.00-1.0%1,866.00-27.1%1,878.00-27.5%1,904.00-33.6%1,889.00-36.3%2,559.00-18.3%2,592.00-15.1%
Accumulated Minority Interest-0.000.000.000.000.000.000.00
Total Equity1,848.00-2.9%1,870.00-1.0%1,866.00-27.1%1,878.00-27.5%1,904.00-33.6%1,889.00-36.3%2,559.00-18.3%2,592.00-15.1%
Total Liabilities & Stockholders Equity4,527.00-1.8%4,578.00-0.9%4,499.00-14.0%4,519.00-13.6%4,611.00-18.3%4,621.00-19.6%5,233.00-12.0%5,231.00-10.8%
Book Value Per Share per share-40.84-1.2%40.75-27.2%41.04-25.3%41.39-32.2%41.33-32.0%56.00-10.4%54.94-9.8%
Tangible Book Value Per Share per share-14.35+8.2%13.91+2.1%13.61-4.7%13.83-11.7%13.26-24.2%13.63-24.4%14.28-8.5%
Full-Time Employees people----2,900-9.4%---
Price to Book Ratio ratio1.841.621.361.421.160.901.081.17
Return on Assets %0.551.63-14.08-13.74-16.03-16.13-1.540.09
Return on Equity %1.333.99-30.96-29.98-34.45-34.43-3.020.18
Return on Invested Capital %-0.490.480.48-0.360.95-22.120.80-4.14
Quick Ratio ratio1.891.891.781.611.511.331.151.27
Current Ratio ratio2.963.053.063.152.852.682.322.52

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q49/30/20262026Q36/30/20262026Q23/31/20262026Q112/31/20252025Q49/30/20252025Q36/30/20252025Q23/31/20252025Q112/31/2024
Net Income-16.00-116.3%16.0016.00-12.0098.00+512.5%-2,180.00-36433.3%-242.00-300.0%-165.00-734.6%
Depreciation44.00-12.0%48.00-36.8%45.00-25.0%48.00-5.9%50.00-5.7%76.00+24.6%60.00-27.7%51.00-33.8%
Other Funds (Non Cash)37.00-3.00-100.1%5.00-98.0%-10.00-105.1%-91.00-578.9%2,147.00+1674.4%252.00196.00
Funds from Operations68.00-45.6%62.00+31.9%68.00-8.1%27.00-65.8%125.0047.00-74.9%74.00-18.7%79.00+132.4%
Extraordinary Item-0.000.000.000.000.000.000.00
Changes in Working Capital22.0056.00-17.6%-18.0098.00-85.00-154.1%68.00-65.00-109.00-165.3%
Cash from Operating Activities90.00+125.0%118.00+2.6%50.00+455.6%125.0040.00-50.0%115.00-9.4%9.00-83.3%-30.00-114.9%
Capital Expenditures-37.00-20.00-17.00-14.00-34.00-20.00-21.00-23.00
Net Assets From Acquisitions-0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.002.000.00-100.0%4.00-11.000.0027.000.00
Purchase or Sale of Investments22.00-4.3%19.00+18.8%18.00-5.3%15.00+150.0%23.00+21.1%16.00-30.4%19.00-9.5%6.00-62.5%
Purchase of Investments-31.00-13.00-15.00-12.00-18.00-12.00-19.00-5.00
Sale Or Maturity of Investments53.00+29.3%32.00+14.3%33.00-13.2%27.00+145.5%41.00+24.2%28.00-33.3%38.00+18.8%11.00-56.0%
Other Uses-18.00-8.00-9.00-24.00-17.00-9.00-16.00-11.00
Other Sources4.00-82.6%5.000.0%15.005.0023.00-11.5%5.00+400.0%0.000.00
Cash from Investing Activities-29.00-2.007.00-22.2%-14.00-16.00-8.009.00-28.00
Cash Dividends Paid-19.00-19.00-19.00-19.00-19.00-19.00-19.00-19.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00-100.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00-100.000.00
Sale of Common Pref Stock-0.000.000.000.000.000.000.00
Proceedsfrom Stock Options-0.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.000.00-100.0%0.000.00-50.0050.000.00
Change in Long Term Debt-0.000.000.000.000.000.000.00
Issuance of Long Term Debt-0.000.000.000.000.000.000.00
Reduction of Long Term Debt-0.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-2.00-300.0%1.000.00-2.001.00-1.000.00-3.00
Other Financing Activities Uses-2.00-300.0%1.000.00-2.001.00-1.000.00-3.00
Cash from Financing Activities-21.00-18.00-19.00-21.00-18.00-70.00-69.00-22.00
Exchange Rate Effect0.00-100.0%-1.00-150.0%1.00-1.002.002.000.00-100.0%-1.00-200.0%
Net Change in Cash40.00+400.0%97.00+148.7%39.0089.008.0039.00-51.00-81.00-452.2%
Free Cash Flow53.00+783.3%98.00+3.2%33.00111.006.00-85.7%95.00-3.1%-12.00-160.0%-53.00-132.1%
Price to Free Cash Flow ratio14.2717.6215.1421.76---111.95

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Region
Name20252025 share
Non-US1,360.0074.6%
United States464.0025.4%
Total1,824.00100.0%
Segment
Name20252025 share
Consolidation, Policy-42.00-2.3%
Intermediates And Solvents137.007.5%
Life Sciences641.0035.1%
Personal Care And Household577.0031.6%
Specialty Additives511.0028.0%
Total1,824.00100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.23%5.1M45.2M595.04K
2026-10-1511.22%5.1M45.2M672.28K
2026-09-3010.23%4.6M45.2M677.33K
2026-09-159.74%4.4M45.2M790.65K
2026-08-3110.66%4.8M45.2M876.93K
2026-08-149.43%4.3M45.2M962.48K
2026-07-319.91%4.5M45.2M1.03M
2026-07-1512.60%5.7M45.2M1.03M
2026-06-3012.69%5.7M45.2M1.03M
2026-06-1512.45%5.6M45.1M922.81K
2026-05-2912.18%5.5M45.2M825.70K
2026-05-1511.37%5.1M45.2M799.12K
2026-04-3012.40%5.6M45.2M733.47K
2026-04-1512.12%5.5M45.1M673.21K
2026-03-3110.82%4.9M45.1M691.01K
2026-03-1311.07%5.0M45.1M683.70K
2026-02-2711.13%5.0M45.1M786.72K
2026-02-139.35%4.2M45.1M790.07K
2026-01-308.63%3.9M45.1M825.97K
2026-01-158.46%3.8M45.1M834.20K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call35.0038.8042.600.004.7310.000.000.980-0.0920.005
call40.0033.7037.600.004.0490.000.000.918-0.4130.017
call45.0028.8032.600.003.4480.000.000.904-0.3980.019
call50.0023.8027.600.002.9530.000.000.886-0.3790.021
call55.0018.8022.700.002.4510.000.000.864-0.3560.024
call60.0013.7017.700.001.9810.000.000.834-0.3270.027
call65.009.7012.7013.101.5291000.000.791-0.2890.032
call70.004.808.108.101.1811980.000.714-0.2450.037
call75.001.504.203.600.9217590.000.537-0.1990.044
call80.000.003.600.751.24422.000.000.394-0.3160.042
call85.000.003.400.401.5502520.000.337-0.3990.040
call90.000.003.400.201.8263.000.000.302-0.4500.039
call95.000.003.400.152.0891.000.000.276-0.4940.037
call1000.003.400.002.3140.000.000.258-0.5290.036
put35.000.003.400.002.8030.000.00-0.019-0.0920.005
put40.000.003.400.003.8910.000.00-0.082-0.4120.017
put45.000.003.400.003.3110.000.00-0.096-0.3960.019
put50.000.003.400.302.7882.000.00-0.114-0.3770.021
put55.000.003.400.502.3074.000.00-0.136-0.3530.024
put60.000.003.401.301.85611.000.00-0.166-0.3240.027
put65.000.003.400.101.4221020.00-0.209-0.2860.032
put70.000.003.501.551.02915.000.00-0.269-0.2380.037
put75.000.002.051.400.54956.000.00-0.437-0.1980.044
put80.002.606.500.000.8160.000.00-0.606-0.3110.042
put85.007.5011.200.001.0540.000.00-0.662-0.3940.040
put90.0012.5016.400.001.3790.000.00-0.699-0.4480.038
put95.0017.2021.700.001.6520.000.00-0.724-0.4900.037
put10022.2026.800.001.8690.000.00-0.743-0.5260.036

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-038-KCurrent report2026-11-03SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-28SCHEDULE 13G/ASEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-258-KCurrent report2026-09-24SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-21SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-108-K/A2026-07-27SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-08-053Initial statement of beneficial ownership of securities2026-07-27SEC
2026-08-053Initial statement of beneficial ownership of securities2026-07-27SEC
2026-08-05SCHEDULE 13GSEC
2026-07-31SCHEDULE 13GSEC
2026-07-318-KCurrent report2026-07-30SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-294Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-07-288-KCurrent report2026-07-27SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-28SCHEDULE 13GSEC
2026-07-08SCHEDULE 13G/ASEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-1711-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.12.48%
Standard Investments LLC9.88%
DIMENSIONAL FUND ADVISORS LP5.74%
FRANKLIN TEMPLETON INC5.56%
VANGUARD PORTFOLIO MANAGEMENT LLC5.38%
VANGUARD CAPITAL MANAGEMENT LLC4.51%
FRONTIER CAPITAL MANAGEMENT CO LLC4.37%
Ancora Advisors LLC4.25%
STATE STREET CORP4.20%
COOPERMAN LEON G4.14%

Funds

Fund% owned
PGIM High Yield Fund79.42%
DFA Global Core Plus Fixed Income Portfolio26.36%
PGIM Total Return Bond Fund24.33%
Loomis Sayles Strategic Income Fund23.78%
BrandywineGLOBAL - CORPORATE CREDIT FUND18.63%
Columbia Strategic Income Fund14.31%
Federated Hermes Institutional High Yield Bond Fund14.14%
iShares Broad USD High Yield Corporate Bond ETF11.53%
DWS High Income Fund11.05%
Columbia High Yield Bond Fund9.35%

OakChart. ASH. Cached 15 minutes. Terms